Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,105 across all filing types
Latest filing 2016-03-16 Remuneration Information
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
DEFA14A
Remuneration Information Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically titled as a Definitive Additional Materials for the Johnson & Johnson Annual Shareholder Meeting held on April 28, 2016. It includes voting instructions, meeting details, and a list of voting items such as election of directors and shareholder proposals. The content is typical of proxy solicitation materials sent to shareholders to inform them and solicit votes for the annual meeting. It is not the actual Annual Report, nor an earnings release or other financial report. The document is not a report publication announcement but the proxy statement itself. Therefore, the correct classification is Remuneration Information (DEF 14A), which covers proxy statements detailing executive compensation and related shareholder voting matters.
2016-03-16 English
DEF 14A
Proxy Solicitation & Information Statement
2016-03-16 English
Director's Dealing 2016
Director's Dealing
2016-03-10 English
Director's Dealing 2016
Director's Dealing
2016-03-10 English
Director's Dealing 2016
Director's Dealing
2016-03-10 English
Director's Dealing 2016
Director's Dealing
2016-03-10 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.